DRRX
DURECT Corp
Price:  
1.91 
USD
Volume:  
2,784,110.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRRX EV/EBITDA

-284.9%
Upside

As of 2025-09-18, the EV/EBITDA ratio of DURECT Corp (DRRX) is -5.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRRX's latest enterprise value is 52.80 mil USD. DRRX's TTM EBITDA according to its financial statements is -10.46 mil USD. Dividing these 2 quantities gives us the above DRRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.8x - 10.8x 7.6x
Forward P/E multiples 12.1x - 17.4x 14.6x
Fair Price (3.85) - (3.44) (3.53)
Upside -301.8% - -279.9% -284.9%
1.91 USD
Stock Price
(3.53) USD
Fair Price

DRRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-10 -5.05
2025-09-09 -5.11
2025-09-08 -5.20
2025-09-05 -5.05
2025-09-04 -5.05
2025-09-03 -5.14
2025-09-02 -5.14
2025-08-29 -5.08
2025-08-28 -5.14
2025-08-27 -5.11
2025-08-26 -5.11
2025-08-25 -5.14
2025-08-22 -5.08
2025-08-21 -5.02
2025-08-20 -5.02
2025-08-19 -4.96
2025-08-18 -5.02
2025-08-15 -5.05
2025-08-14 -5.02
2025-08-13 -5.02
2025-08-12 -5.05
2025-08-11 -4.93
2025-08-08 -4.93
2025-08-07 -4.96
2025-08-06 -4.90
2025-08-05 -4.87
2025-08-04 -4.90
2025-08-01 -4.82
2025-07-31 -4.93
2025-07-30 -5.05
2025-07-29 -4.96
2025-07-28 -1.02
2025-07-25 -1.06
2025-07-24 -1.12
2025-07-23 -1.14
2025-07-22 -1.01
2025-07-21 -1.06
2025-07-18 -0.97
2025-07-17 -0.93
2025-07-16 -1.05
2025-07-15 -0.95
2025-07-14 -1.04
2025-07-11 -1.24
2025-07-10 -1.27
2025-07-09 -1.30
2025-07-08 -1.23
2025-07-07 -1.28
2025-07-03 -1.36
2025-07-02 -1.36
2025-07-01 -1.28